Stem cell conference finds no magic bullet:
This article was originally published in Clinica
A recent stem cell conference held in London, with speakers from private and public companies, demonstrated that there is no singular solution to cell therapies using stem cells, according to analysts WestLB Panmure. While the analysts concluded the science is "riveting", it will take time before the commercial potential of stem cells will "mirror the hype".
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.